tirzepatide breastfeeding Big news for postpartum moms: The Zepbound (tirzepatide) label has been updated with new data — and the results are reassuring., A clinical study in lactating women found that Tirzepatide and Breastfeeding: What Moms

Who Is at Increased Risk for Uterine Bleeding While Taking Semaglutide

Future GLP-1 trends: new drugs and therapies on the horizon The future of weight management may soon involve more than current GLP-1s: Amylin mimetics: These compounds mimic another satiety hormone and may complement GLP-1s. Mazdutide: A dual glucagon/GLP-1 agonist showing strong Phase 3 results and promising greater weight loss. Oral GLP-1s: Pills in development could improve convenience. Muscle-preserving combinations: Researchers are exploring co-therapies to prevent loss of lean mass during weight loss. Providers should prepare for a rapidly evolving landscape and educate patients about upcoming options. Key takeaways on GLP-1 trends for providers and patients Efficacy varies across drugs and doses

3.2.5 Disturbed energy metabolism Epilepsy characterized by sustained high-frequency discharges consumes a large amount of energy, which can disrupt lactate-pyruvate metabolic coupling in astrocytes

Your healthcare provider will conduct a thorough assessment to determine whether the taste change is related to Ozempic, another medication, or an underlying condition

(4) Grillo MS, Frank J, Saenger P